Kimera–Test® is the first genetic test capable of HPV genotyping and detection of genetic susceptibility to cervical and prostate cancer simultaneously.
Urine Test non-invasive.
Detection and genotyping of 15 types of high-risk HPV (Human Papilloma Virus).
Identification of polymorphisms for cervical cancer risk.
Identification of polymorphisms for prostate cancer risk.
Results from1 to 5 days.
High Precision and Sensibility
Clear results that allow the doctor and the patient to choose a personalized monitoring plan and selection of treatment.
Recomended for men and women with a sexually active life.